Aixial Group is reporting that it has become a mid-size, global CRO, with a strong U.S. and European presence and more than 1,000 employees. The announcment follows the company’s acqusition of Larix in 2019 and Cmed in 2021. With over 30 years’ experience in project delivery, Aixial Group continues to grow with the full integration of Larix and Cmed enabling it to extend its expertise and offerings, with more options for biotech and pharma sponsors at both the local and global levels. ...